This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2008 by Sun Yat-sen University.
Recruitment status was:  Recruiting
Information provided by:
Sun Yat-sen University Identifier:
First received: November 24, 2008
Last updated: NA
Last verified: November 2008
History: No changes posted
This study is to investigate whether preoperative biliary drainage can reduce the postoperative morbidity in patients with hilar cholangiocarcinoma.

Condition Intervention Phase
Cholangiocarcinoma Drainage Surgery Procedure: Preoperative biliary drainage Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Effect of Preoperative Biliary Drainage on Postoperative Complications in Resectable Patients With Hilar Cholangiocarcinoma(Klatskin Tumor)

Resource links provided by NLM:

Further study details as provided by Sun Yat-sen University:

Primary Outcome Measures:
  • Incidence of postoperative complication [ Time Frame: 30 days after operation ]

Secondary Outcome Measures:
  • Postoperative mortality [ Time Frame: 30 days after operation ]
  • Overall survival, OS [ Time Frame: May, 2013 ]
  • Disease free survival, DFS [ Time Frame: May, 2013 ]

Estimated Enrollment: 82
Study Start Date: May 2008
Estimated Study Completion Date: May 2013
Estimated Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Preoperative biliary drainage Procedure: Preoperative biliary drainage
Percutaneous transhepatic biliary drainage(PTBD) is performed under the guidance of ultrasound. The duration may be around four weeks to make the total bilirubin of patients lower than 85μmol/L.
No Intervention: Controlled group

Detailed Description:
Preoperative biliary drainage(PBD) or not, is a Hot Spot issue in the management of Hilar cholangiocarcinoma. Surgeons from Japan tend to perform PTBD(Percutaneous Transhepatic Biliary Drainage) before a definite operation until the total bilirubin(TB) lower than 85μmol/L. For some patients needed to perform extended curative resection, PVE(Portal Vein Embolization) is performed and thus the duration of PBD may be around six weeks and the final TB is lower than 34μmol/L. Some tend to perform a definite curative operation in a short time after diagnosis. There is no RCT research on the effect of PBD for the resectable Hilar Cholangiocarcinoma patients to date.

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients newly diagnosed
  • Resectable patients after imaging assessment and evaluation of general condition of the patient
  • TB>85μmol/L
  • WBC account more than 1.5×109/L, PLT account more than 100×109/L and HB account more than 100g/L
  • No serious disease in heart, lung and kidney
  • Written informed consent

Exclusion Criteria:

  • Unresectable patients.
  • Patients have received biliary drainage procedure such as PTBD before admission
  • Complicated with chronic hepatitis
  • Myocardia infarction record within six months
  • Women in pregnancy
  • Serious disease in heart, lung or kidney
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00797121

Contact: Lijian Liang 86-20-87755766 ext 8096

China, Guangdong
Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University Recruiting
Guangzhou, Guangdong, China, 510080
Contact: Dong Chen, MD    86-20-87755766 ext 8096   
Principal Investigator: Lijian Liang         
Sponsors and Collaborators
Sun Yat-sen University
Study Chair: Lijian Liang Department of hepatobiliary, the first affiliated hospital, Sun Yat-sen University
Principal Investigator: Xiaoyu Yin, MD Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University
  More Information

Responsible Party: Liang Li-jian, the First affiliated hospital, Sun Yat-Sen University Identifier: NCT00797121     History of Changes
Other Study ID Numbers: SUMS-5010
Study First Received: November 24, 2008
Last Updated: November 24, 2008

Keywords provided by Sun Yat-sen University:

Additional relevant MeSH terms:
Postoperative Complications
Klatskin Tumor
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Pathologic Processes processed this record on September 19, 2017